MyAverix Finance
US · Healthcare
Instadose Pharma Corp (INSD)
Drug Manufacturers - Specialty & Generic
Instadose Pharma Corp (INSD) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for INSD
Instadose Pharma Corp (INSD) — FAQ
What is INSD's P/E ratio?
The price-to-earnings (P/E) ratio for Instadose Pharma Corp (INSD) is 18.00 (data as of 2026-03-24).
Does Instadose Pharma Corp pay a dividend?
Dividend yield is not available in the current snapshot for Instadose Pharma Corp (INSD). Check the MyAverix Finance app for the latest dividend data.
What sector is Instadose Pharma Corp in?
Instadose Pharma Corp (INSD) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is INSD listed on?
INSD is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.